What does this research mean for the field?

The VerifyNow platform is a user-friendly, point-of-care platelet function test system that produces rapid bedside results to effectively monitor antiplatelet therapy and segregate responders from non-responders. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the underlying mechanisms, clinical utility, and interpretive cut-off values of the VerifyNow point-of-care system for monitoring patient responsiveness to antiplatelet regimens.

January 1, 2008Platelets

The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidence

Q: What is the clinical evidence from this study?

Study design: Review. Population: Acute coronary syndromes and coronary stent implantation. Intervention: VerifyNow system.

View Full Paper

Ask AI

Bookmark

Key result

The VerifyNow platform is a point-of-care platelet function test system that produces rapid bedside results to monitor antiplatelet therapy and segregate responders from non-responders.

Key Points

To review the underlying mechanisms, clinical utility, and interpretive cut-off values of the VerifyNow point-of-care system for monitoring patient responsiveness to antiplatelet regimens.
Synthesized evidence examining interindividual response variability and residual platelet reactivity under aspirin, clopidogrel, and glycoprotein IIb/IIIa inhibitors.
Evaluated the operational principles, clinical outcomes data, and threshold cut-offs established for the bedside VerifyNow platelet function platform.
Interindividual response variability and heightened residual platelet reactivity significantly associate with elevated rates of secondary adverse cardiovascular events.
A substantial subset of patients fails to reach minimum platelet inhibition thresholds under standard weight-adjusted glycoprotein IIb/IIIa or dual antiplatelet dosing.
The VerifyNow platform provides rapid bedside risk stratification, distinguishing responders from non-responders to guide individualized antiplatelet optimization.

Structured PICO

Population

Patients with acute coronary syndromes or undergoing coronary stent implantation receiving antiplatelet therapy

Intervention

VerifyNow system for monitoring antiplatelet therapy

The VerifyNow system is a user-friendly point-of-care platelet function test that may help identify patients with impaired responsiveness to antiplatelet therapy, potentially improving risk stratification and clinical outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May aid bedside identification of antiplatelet non-responders; leaves open whether routine use improves outcomes.

Cite This Study

Werkum et al. (2008) conducted a review in Acute coronary syndromes and coronary stent implantation. VerifyNow system was evaluated. The VerifyNow platform is a point-of-care platelet function test system that produces rapid bedside results to monitor antiplatelet therapy and segregate responders from non-responders.

synapsesocial.com/papers/6a183ca7d990e918e6b51204 https://doi.org/10.1080/09537100802317918

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidence

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidence

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider